| Typ : |
Tidningen |
| Internet länkar : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3804 |
|
| Forskargrupper : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
| Författare : |
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
| Titel : |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. |
| Hänvisningar : |
Int J Pharm Compound ; 18, 2 : 169-174. 2014 |
|
| Evidensgrad : |
|
| Fysikalisk stabilitet : |
|
| Kemisk stabilitet : |
|
| Andra metoder : |
|
| Kommentarer : |
|
Förteckning över substanser
 Valsartan
|
 |
 |
 |
 |
400 mg
Valzan® (Pharmacare PLC) |
| Xantangummi |
20 mg |
| Hydroxipropylmetylcellulosa |
20 mg |
| Aerosil® |
110 mg |
| Banansmak |
20 mg |
| Natriumfosfat |
80 mg |
| Titandioxid |
1 mg |
| Jordgubbssmak |
110 mg |
| Sackaros |
22,04 g |
| Renat vatten |
>> 25 mL |
|
23-27°C |
 |
| 30 |
 |
|
|
|
|
|
400 mg
Valzan® (Pharmacare PLC) |
| Xantangummi |
20 mg |
| Hydroxipropylmetylcellulosa |
20 mg |
| Aerosil® |
110 mg |
| Banansmak |
20 mg |
| Natriumfosfat |
80 mg |
| Titandioxid |
1 mg |
| Jordgubbssmak |
110 mg |
| Sackaros |
22,04 g |
| Renat vatten |
>> 25 mL |
|
38-42°C |
|
| 30 |
|
|
|
|
|
